Avidity Biosciences
RNA
#1875
Rank
S$14.07 B
Marketcap
S$93.44
Share price
0.15%
Change (1 day)
140.41%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: S$14.07 Billion

As of January 2026 Avidity Biosciences has a market cap of S$14.07 Billion. This makes Avidity Biosciences the world's 1875th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$14.07 B0.9%
2025S$13.95 B185.76%
2024S$4.88 B415.99%
2023S$0.94 B-52.14%
2022S$1.97 B31.19%
2021S$1.50 B18.95%
2020S$1.26 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Avidity Biosciences was reported to be:

S$14.05 Billion
by Nasdaq info icon info icon
S$14.05 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
S$7.99 B-43.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.05 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$3.07 B-78.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$3.66 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.16 B-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$14.08 B 0.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$187.34 B 1,230.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$132.22 B 839.15%๐Ÿ‡ฌ๐Ÿ‡ง UK